A Clinical Decision Support System for Diabetic Retinopathy Screening: Creating a Clinical Support Application

Telemed J E Health. 2019 Jan;25(1):31-40. doi: 10.1089/tmj.2017.0282. Epub 2018 Feb 21.

Abstract

Background: The aim of this study was to build a clinical decision support system (CDSS) in diabetic retinopathy (DR), based on type 2 diabetes mellitus (DM) patients.

Method: We built a CDSS from a sample of 2,323 patients, divided into a training set of 1,212 patients, and a testing set of 1,111 patients. The CDSS is based on a fuzzy random forest, which is a set of fuzzy decision trees. A fuzzy decision tree is a hierarchical data structure that classifies a patient into several classes to some level, depending on the values that the patient presents in the attributes related to the DR risk factors. Each node of the tree is an attribute, and each branch of the node is related to a possible value of the attribute. The leaves of the tree link the patient to a particular class (DR, no DR).

Results: A CDSS was built with 200 trees in the forest and three variables at each node. Accuracy of the CDSS was 80.76%, sensitivity was 80.67%, and specificity was 85.96%. Applied variables were current age, gender, DM duration and treatment, arterial hypertension, body mass index, HbA1c, estimated glomerular filtration rate, and microalbuminuria.

Discussion: Some studies concluded that screening every 3 years was cost effective, but did not personalize risk factors. In this study, the random forest test using fuzzy rules permit us to build a personalized CDSS.

Conclusions: We have developed a CDSS that can help in screening diabetic retinopathy programs, despite our results more testing is essential.

MeSH terms

  • Age Factors
  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Blood Pressure
  • Body Mass Index
  • Decision Support Systems, Clinical / organization & administration*
  • Decision Trees*
  • Diabetic Retinopathy / diagnosis*
  • Diabetic Retinopathy / epidemiology*
  • Glycated Hemoglobin
  • Humans
  • Kidney Function Tests
  • Mass Screening / organization & administration*
  • Middle Aged
  • Prospective Studies
  • Risk Factors
  • Sensitivity and Specificity
  • Sex Factors

Substances

  • Glycated Hemoglobin A